blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0036718

EP0036718 - 7-Chloro-3-substituted aryl-3,4-dihydro-1,9(2H,10H) and 10-hydroxy acridinedioneimines, processes for producing the acridinedioneimines, and pharmaceutical compositions containing the acridinedioneimines [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.11.1985
Database last updated on 30.10.2024
Most recent event   Tooltip12.11.1985No opposition filed within time limitpublished on 15.01.1986 [1986/03]
Applicant(s)For all designated states
WARNER-LAMBERT COMPANY
201 Tabor Road Morris Plains
New Jersey 07950 / US
[N/P]
Former [1981/39]For all designated states
WARNER-LAMBERT COMPANY
201 Tabor Road
Morris Plains New Jersey 07950 / US
Inventor(s)01 / Werbel, Leslie Morton
1570 Covington Drive
Ann Arbor Michigan 48103 / US
[1981/39]
Representative(s)Jones, Michael Raymond, et al
Haseltine Lake & Co., Imperial House, 15-19 Kingsway
London WC2B 6UD / GB
[N/P]
Former [1981/39]Jones, Michael Raymond, et al
HASELTINE LAKE & CO. Hazlitt House 28 Southampton Buildings Chancery Lane
London WC2A 1AT / GB
Application number, filing date81300934.706.03.1981
[1981/39]
Priority number, dateUS1980013236220.03.1980         Original published format: US 132362
[1981/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0036718
Date:30.09.1981
Language:EN
[1981/39]
Type: A3 Search report 
No.:EP0036718
Date:02.12.1981
Language:EN
[1981/48]
Type: B1 Patent specification 
No.:EP0036718
Date:02.01.1985
Language:EN
[1985/01]
Search report(s)(Supplementary) European search report - dispatched on:EP30.09.1981
ClassificationIPC:C07D219/08, C07D219/06, A61K31/435
[1981/39]
CPC:
C07D219/08 (EP,US); A61P33/02 (EP); C07C45/45 (EP,US);
C07C45/74 (EP,US); C07C49/235 (EP,US); C07D219/06 (EP,US);
Y02A50/30 (EP) (-)
C-Set:
C07C45/45, C07C49/697 (EP,US);
C07C45/74, C07C49/235 (US,EP)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1981/39]
TitleGerman:In 3-Stellung durch Aryl substituierte 7-Chlor-3,4-dihydro-1,9(2H,10H)- und -10-hydroxyacridindionimine, Verfahren zu ihrer Herstellung und diese Acridindionimine enthaltende pharmazeutische Zusammensetzungen[1981/39]
English:7-Chloro-3-substituted aryl-3,4-dihydro-1,9(2H,10H) and 10-hydroxy acridinedioneimines, processes for producing the acridinedioneimines, and pharmaceutical compositions containing the acridinedioneimines[1981/39]
French:7-Chloro-3,4-dihydro-1,9(2H, 10H)- et -10-hydroxyacridinedioneimines substituées en position 3 par des groupes aryles, procédé pour leur préparation et compositions pharmaceutiques contenant les acridinedioneimines[1981/39]
Examination procedure15.10.1981Examination requested  [1981/51]
28.07.1982Despatch of a communication from the examining division (Time limit: M06)
29.01.1983Reply to a communication from the examining division
22.06.1983Despatch of a communication from the examining division (Time limit: M04)
24.10.1983Reply to a communication from the examining division
09.03.1984Despatch of communication of intention to grant (Approval: )
13.06.1984Communication of intention to grant the patent
30.08.1984Fee for grant paid
30.08.1984Fee for publishing/printing paid
Opposition(s)03.10.1985No opposition filed within time limit [1986/03]
Fees paidRenewal fee
25.02.1983Renewal fee patent year 03
24.02.1984Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2383458  ;
 DE2337474  [ ] (HOECHST AG);
 DE2748333  [ ] (HOECHST AG)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.